Dr Amit Bahl

Consultant Clinical Oncologist

Practising at

Spire Bristol Hospital

Spire Oncology Centre South West

Back to top

Treatment information

Some of the principal treatments carried out by Dr Amit Bahl at Spire include:

Other treatments

  • Chemotherapy
  • Radiotherapy

Back to top

Professional profile

I am a Consultant Clinical Oncologist at Bristol Haematology and Oncology Centre with a special interest in breast and urological cancers.

I have led and developed the prostate brachytherapy service at Bristol and been an expert adviser to NICE for the technology appraisal of new drugs and an external service reviewer.

I am a current member of the National Cancer Research Institute for prostate and bladder cancer, and have supervised several research projects. I am actively involved in research into breast, prostate and bladder cancers and participate in clinical trials. I regularly publish articles and present at many national and international meetings.

I have previously been in the NCRI Renal clinical studies group and I am an Executive Committee member of the British Uro-oncology group. I have been awarded the fellowship of the Royal College of Physicians. and in 2012 was awarded the Cochrane Shanks Jalil Professorship by the Royal College of Radiologists, London.

Clinical Interests

Bladder cancer
Breast cancer
Genito-urinary cancer
Kidney cancer
Prostate cancer

Private contact details

Private secretary Donna Bastin
Private secretary telephone 01454 456 544
Private secretary fax 01454 456523
Private secretary email
Back to top

Qualification and professional memberships

Professional memberships

Royal College of Physicians London
Royal College of Radiologists London
NCRI Prostate and Bladder Cancer Clinical Studies Groups
British Uro-Oncology Group

Professional leadership

Chair of Penile Cancer Subgroup

Back to top

Current NHS posts

Consultant Clinical Oncologist, Bristol Cancer Institute, University Hospitals Bristol NHS Trust

Back to top

Financial Interests

Dr Bahl is a national cancer consultant adviser for Spire for a payment of £12,000 per annum. Duties include advising the Spire Group Medical Director on various matters relating to cancer, including clinical governance and national cancer standards. He is also an Oncology adviser at Spire Oncology Centre, South West for a payment of £12,000 per annum. Duties include advisory services on clinical governance, treatment protocols, quality assurance and technology and information systems in relation to the centre.

Back to top